Large-scale testing (Phase 3)Study completedNCT03930615
What this trial is testing
Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)
Who this might be right for
Cytomegalovirus Infection
Merck Sharp & Dohme LLC 220